BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Alprenolol

One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.

300+ PubMed studies analyzed · 20 RCTs · Evidence Score: 47.6

Research Domains

Alprenolol has been studied across 17 research domains including ❤️ Cardiovascular, 🌤️ Mood & Depression, 🧠 Focus & Attention, 🫁 Liver & Detox, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 35% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Alprenolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Carteolol
4 shared targets
Celiprolol
4 shared targets
Oxprenolol
4 shared targets
Fenoterol
5 shared targets
Nylidrin
8 shared targets
Timolol
6 shared targets
Acebutolol
4 shared targets
Atenolol
5 shared targets
Bupranolol
4 shared targets
levisoprenaline
3 shared targets
Loading evidence profile...

This evidence profile for Alprenolol is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.